TransMedics will appoint Fernando Araujo as chief financial officer and treasurer on September 21, with a $590,000 annual base salary, replacing Gerardo Hernandez. The transition matters to investors because TransMedics also reaffirmed 2026 Revenue guidance of $737 million to $757 million, equal to approximately 22% to 25% year-over-year growth.
Key Highlights
- Fernando Araujo will become TransMedics’ chief financial officer and treasurer on September 21, 2026, with a $590,000 annual base salary.
- Fernando Araujo will receive a $200,000 cash sign-on Bonus and initial stock awards valued at approximately $1,750,000 each.
- Gerardo Hernandez will remain a non-executive employee through December 31 before serving as a senior advisor until April 30, 2027.
TransMedics Group, Inc. (NASDAQ: TMDX) will appoint Fernando Araujo as chief financial officer and treasurer on September 21, with an annual base salary of $590,000. He will succeed Gerardo Hernandez, who has held the CFO post since 2024.
Araujo’s Compensation and Hernandez Transition
The employment arrangements also provide severance benefits for qualifying terminations, change-in-control protections and continued health coverage. Araujo will be subject to confidentiality, intellectual property, non-competition and non-solicitation provisions after employment ends. Hernandez will remain a non-executive employee through December 31 while continuing to receive an annual base salary of $535,000 and eligibility for the 2026 annual bonus. He will then serve as a non-employee senior advisor through April 30, 2027, with outstanding Equity awards continuing to vest and no additional remuneration for advisory services.
FAQs
Q: Who is TransMedics appointing as CFO?
A: TransMedics is appointing Fernando Araujo as chief financial officer and treasurer on September 21. He succeeds Gerardo Hernandez, who has served as CFO since 2024.
Q: What 2026 revenue guidance did TransMedics reiterate?
A: TransMedics reiterated its 2026 revenue outlook of $737 million to $757 million. That range represents approximately 22% to 25% year-over-year growth.
Q: What compensation will Fernando Araujo receive at TransMedics?
A: Araujo’s package includes a $200,000 cash sign-on bonus and initial stock option and restricted stock unit awards, each valued at approximately $1,750,000.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.